You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


Introducing Nucala® (mepolizumab)

A targeted anti-IL-5 add-on treatment for adults with severe refractory eosinophilic asthma.

Find out more

Prescribing information


How to use Ellipta video

Video: How to use the Ellipta inhaler

A useful step-by-step guide designed to help patients use their inhaler correctly.

Watch the video



Our vaccines ordering website is packed with features designed to save you time and help you manage your GSK vaccines purchases more effectively. It could even help you save money with online discounts.

Find out more



View the latest stock availability of our products.

Supply page

Expert perspectives

Respiratory Knowledge base

Watch videos on everything from disease and patient management to research and development.

Find out more

View our products

View our products

Find information on our products including resources for patients.

Adverse events should be reported. Reporting forms and information can be found at .
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Nucala and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies.